Advertisement
Advertisement

KLTO

KLTO logo

Klotho Neurosciences Inc.

0.444
USD
-0.004
-0.89%
Jan 22, 14:14 UTC -5
Closed
...

Klotho Neurosciences Inc. Profile

About

Klotho Neurosciences Inc. is a pharmaceutical company. It specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system which are seen as key developments in treating neurodegenerative and age-related disorders. Klotho Neurosciences Inc., formerly known as ANEW MEDICAL INC., is based in NEW YORK.

Info & Links

CEO

Jiande Chen

Headquarters

1115 BROADWAY, 12TH FLOOR
New York, NY 10010, UNITED STATES

Sector

Finance

Auditor

Marcum llp

Share holders

6

Employees

2

Klotho Neurosciences Inc. Statistics

Valuation Measures

Market Capitalization2

9.44M

Enterprise Value

9.54M

Enterprise Value/EBITDA(ttm)

-2.26

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.81

Price to Cash(ytd)

1.03

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-108.96%

Return on Assets(ttm)

-25.89%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-4.22M

Net Income Available to Common(ttm)

-2.90M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

-95.85%

S&P 500 52-Week Change

25.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

21.26M

Dividend Yield

0.00%

Float4

20.84M

% Held by Insiders

2.00%

% Held by Institutions

20.07%

Balance Sheet

Total Cash(mrq)

50.90K

Total Cash Per Share(mrq)

0.00

Total Debt(mrq)

151.00K

Total Debt/Equity(mrq)

10.34%

Current Ratio(mrq)

0.16%

Quick Ratio(mrq)

0.16%

Book Value Per Share(mrq)

0.07

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.12

Free Cash Flow(ytd)

-2.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement